# Study to Evaluate the Long-Term Safety of PA32540 in Subjects Who Are at Risk for Developing Aspirin-Associated Gastric Ulcers

> **NCT00995410** · PHASE3 · COMPLETED · sponsor: **POZEN** · enrollment: 380 (actual)

## Conditions studied

- Aspirin-Associated Gastric Ulcers

## Interventions

- **DRUG:** PA32540

## Key facts

- **NCT ID:** NCT00995410
- **Lead sponsor:** POZEN
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2011-05
- **Final completion:** 2011-05
- **Target enrollment:** 380 (ACTUAL)
- **Last updated:** 2016-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00995410

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00995410, "Study to Evaluate the Long-Term Safety of PA32540 in Subjects Who Are at Risk for Developing Aspirin-Associated Gastric Ulcers". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT00995410. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*